NASHVILLE, Tenn.--(EON: Enhanced Online News)--Scientific researchers and pharmaceutical executives from across the world will join life science executives from across Tennessee this week at the Music City Center as two life science organizations, the Academic Drug Discovery Consortium (ADDC) and Life Science Tennessee (LifeSciTN) merge their conferences October 9 through 11.
“We are thrilled to have received such a tremendous response from academia, industry, government agencies and private foundations”
The combined conference, a landmark event for the pharmaceutical and life science industries, is being hosted by Vanderbilt’s Center for Neuroscience Drug Discovery (VCNDD) and Life Science Tennessee, the statewide association of life science companies in Tennessee. Nearly 600 people working in all aspects of drug discovery and life science research have registered to attend.
Addressing the conference will be leading keynote speakers and panel participants from such prestigious institutions as AstraZeneca, Bayer, Merck, Pfizer, Roche, the National Institutes of Health, the Institute of Cancer Research, the Michael J. Fox Foundation, Johns Hopkins University, Sanford-Burnham Medical Research Institute, Emory University, Harvard University and the Scripps Research Institute.
“We are thrilled to have received such a tremendous response from academia, industry, government agencies and private foundations,” said P. Jeffrey Conn, Director of VCNDD and a founding member of the ADDC.
Kicking off the conference will be renowned biotechnology entrepreneur John Crowley, whose life story was the basis for the 2010 Harrison Ford movie Extraordinary Measures. Two of Crowley’s children were diagnosed with Pompe’s disease, a rare and fatal neuromuscular disorder. Crowley embarked on a mission to find a treatment and start a company that would eventually save his children and make him a pioneer in the biotech industry.
The conference will focus on the many topics the industry faces including best practices in translational medicine, industry sponsored research, philanthropy and corporate venture funding, federal funding models, the Food and Drug Administration (FDA), public and private insurance reimbursements, creating and adding value to novel intellectual property as well as more scientific topics as the importance of biomarkers in clinical imaging.
The conference will also feature the second annual LifeSciTN Venture Forum designed to showcase and support emerging companies in Tennessee’s life sciences industry which includes the pharmaceutical, medical device, research, biotechnology, biofuels and biologistics subsectors. This year’s competition is sponsored by iStart, a business competition platform of the Kauffman Foundation.
“This conference will highlight Tennessee’s vibrant life science research and development community to the leading national and international government and industry executives. LifeSciTN is proud to co-host the event with VCNDD,” said Sam Lynch, founder of Franklin, Tenn.-based BioMimetic Therapeutics and board chairman of LifeSciTN. “It is a great opportunity to exchange ideas and best practices with leading international experts on the issues that face all of us involved in the discovery and development of life science technologies,” Lynch added.
About the Academic Drug Discovery Consortium
ADDC is a non for profit consortium consisting of academic drug discovery centers and groups across the country working in all therapeutic areas of drug discovery. ADDC officially formed in 2012 and was created by five founding drug discovery scientists: Barbara Slusher, Johns Hopkins Brain Science Institute; P. Jeffrey Conn, Vanderbilt Center for Neuroscience Drug Discovery; Stephen Frye, UNC’s Center for Integrative Chemical Biology and Drug Discovery; Michelle Arkin, UCSD Small Molecule Discovery Center; and Marcie Glicksman, Harvard NeuroDiscovery Center. Their mission is to facilitate collaboration between every sector of the biomedical research community and propel the development of new therapies and pharmaceuticals into the healthcare system. For more information about ADDC or how to join please, visit www.addconsortium.org.
About Life Science Tennessee
Life Science Tennessee (LifeSciTN) is a statewide, non-profit association of more than 80 members whose mission is to advance and grow the life science industry in Tennessee through advocacy, partnerships and alignment with economic and workforce development. Members include companies, universities, research institutions, government and economic development groups, and other industry associations involved in discovery and application of life science products and related services that improve the health and well-being of people throughout the world.